Verrica Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share (VRCA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
VRCA on Nasdaq
Shares outstanding
65,095,636
Price per share
$8.30
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,468,945
Total reported value
$10,583,119
% of total 13F portfolios
0%
Share change
+2,274,817
Value change
+$10,479,754
Number of holders
31
Price from insider filings
$8.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Verrica Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share (VRCA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Manning Paul B 50% $28,437,789 8,056,031 Paul B Manning 25 Nov 2025
Caligan Partners LP 10% 0% $43,635,492 6,503,054 0% Caligan Partners LP 26 Dec 2025
Affinity Asset Advisors, LLC 5.5% $3,421,746 884,172 Affinity Asset Advisors, LLC 25 Nov 2025
ARMISTICE CAPITAL, LLC 6.8% $2,754,922 639,193 Armistice Capital, LLC 30 Sep 2025

As of 30 Sep 2025, 31 institutional investors reported holding 2,468,945 shares of Verrica Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share (VRCA). This represents 3.8% of the company’s total 65,095,636 outstanding shares.

Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share (VRCA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 2,468,945 $10,583,119 +$10,479,754 $4.31 31
2025 Q2 194,004 $102,830 +$102,829 $0.53 4